February 01, 2018
Read the full story at: https://www.pharmaceutical-journal.com/news-and-analysis/features/zika-vaccine-development-two-years-on-from-the-outbreak/20204340.article
Contact
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations
(410) 706-5260
Related stories
Friday, March 29, 2019
12th Annual Dr. Aaron I. Grollman Visiting Professorship in Basic Sciences Lectureship Features Dr. Eva Harris
Eva Harris, PhD, never met a mosquito she didn’t like. A Professor of Infectious Diseases and Vaccinology and Director of the Center for Global Health at the University of California, Berkley, Dr. Harris was recently the guest speaker at the University of Maryland School of Medicine’s (UMSOM) Dr. Aaron I. Grollman Visiting Professorship in Basic Sciences Lectureship, where she shared her research on the control of Zika, dengue, and chikungunya—the most prevalent mosquito-borne diseases in humans. She is also the Co-Founder and President of the Sustainable Sciences Institute (SSI), an international non-profit dedicated to developing sustainable local research and public health systems in resource-poor settings.
Thursday, January 05, 2017
For the First Time, Researchers Identify Key Proteins That May Make Zika So Deadly
Until it burst onto the scene earlier this year, Zika was an obscure, little-known virus. As a result, scientists know little about how it works. Over the past year, they have learned that it can cause a range of dangerous health problems, including birth defects such as microcephaly and neurological problems such as Guillain-Barré syndrome. But they don’t know which Zika protein or proteins are causing harm, or exactly how these proteins cause damage.
Thursday, August 04, 2016
UM SOM is Center Stage in Testing National Institutes of Health Zika Vaccine
UM SOM'S Center for Vaccine Development, tapped previously for Ebola vaccine, now steps up to help develop first Zika vaccine.
Tuesday, February 16, 2016
The Baltimore Sun: Baltimore Consortium Forms Global Task Force to Study Zika, Find Vaccine
A Baltimore-based research consortium is forming a task force of leading scientists from around the world, including renowned AIDS researcher Dr. Robert Gallo, to better understand the Zika virus and quickly develop a vaccine.